Copper Test · Blood

Your body holds only about 80 milligrams of copper at any given time, roughly the weight of a few grains of rice. That tiny reserve powers dozens of enzymes involved in producing energy, building connective tissue, processing iron, and defending cells against damage. But copper is unusual among nutrients: the window between too little and too much is narrow, and drifting in either direction raises the risk of serious disease.

A standard metabolic panel does not include copper. That means you can have a level creeping upward, driven by inflammation, hormonal shifts, or impaired liver clearance, and never know it from routine bloodwork. If you are tracking heart disease risk, brain health, or liver function, knowing your copper level fills a gap that other tests leave open.

What Copper Does in Your Body

Copper (Cu) is not a protein or hormone. It is a metal that easily switches between two electrical states. That switching ability makes it the ideal helper molecule for enzymes that transfer energy inside your cells. Your mitochondria, the energy-producing compartments inside every cell, depend on copper to complete the final step of turning food into usable energy.

Copper also drives the enzyme that loads iron onto its transport protein in blood. Without adequate copper, iron gets stuck in storage, and you can develop anemia even if your iron intake is fine. In the brain, copper helps build the chemical messengers that regulate mood and movement. In your bones and blood vessels, copper-dependent enzymes crosslink collagen and elastin, keeping tissues strong and flexible.

You absorb copper from food in your small intestine through a specialized transporter called CTR1. Your liver then packages most of it into a carrier protein called ceruloplasmin and releases it into the bloodstream. About 85 to 95% of the copper circulating in your blood is bound to ceruloplasmin. The liver also removes excess copper by dumping it into bile for elimination in stool. When this system works well, the small fraction of copper floating freely in your blood (sometimes called "free" or "non-ceruloplasmin" copper) stays very low.

Heart Disease and Mortality

Among the disease connections tied to copper, cardiovascular risk stands out for the strength and consistency of the evidence. In a study of 5,412 U.S. adults from the NHANES survey followed for nearly six years, people in the highest third of serum copper (above 19.84 µmol/L) were about seven times as likely to die from cardiovascular disease as those in the lowest third (below 16.31 µmol/L). Their risk of dying from any cause was nearly three times higher.

Those numbers held up when the researchers combined their results with three other cohorts in a meta-analysis totaling over 13,000 people. In that pooled analysis, people with the highest copper levels had roughly double the risk of cardiovascular death and about 90% higher risk of dying from any cause compared to those with the lowest levels.

A separate study using the Multi-Ethnic Study of Atherosclerosis (MESA), which followed 6,599 adults for up to 19 years, found that people in the highest quarter of urinary copper (a different measurement from serum copper, reflecting copper excreted by the kidneys) had about 42% higher risk of developing cardiovascular disease and 50% higher risk of dying from any cause compared to those in the lowest quarter. A Spanish cohort of 1,171 adults echoed these findings, with a 35% higher cardiovascular risk when comparing the 80th to the 20th percentile of urinary copper.

A large Scottish population study using electronic health records found that elevated plasma copper was associated with higher odds of multiple cardiovascular conditions: roughly 78% higher odds of hypertension, 64% higher odds of ischemic heart disease (reduced blood flow to the heart muscle), and 62% higher odds of cerebrovascular disease (conditions affecting blood flow to the brain) compared to people with normal copper levels.

If your copper comes back elevated, especially above the top third of the reference range, it is worth taking a hard look at your overall cardiovascular risk profile. Consider ordering hs-CRP (high-sensitivity C-reactive protein), ApoB, and a lipid panel to see whether the copper elevation is accompanied by other warning signs.

Liver Disease

The liver is copper's command center. It loads copper into ceruloplasmin, ships it through the bloodstream, and excretes the excess into bile. When liver cells cannot handle copper properly, the consequences range from subtle scarring to outright organ failure.

In 215 adults with biopsy-confirmed MASLD (metabolic dysfunction-associated steatotic liver disease, formerly called NAFLD or non-alcoholic fatty liver disease), researchers measured copper directly in liver tissue obtained during biopsy, a different measurement from the serum copper reported on a blood test. Those with high hepatic copper (50 µg/g dry weight or above) had strikingly higher odds of significant worsening on a fibrosis scoring tool over a median of nearly five years, with an adjusted odds ratio of 41.3 in logistic regression, though this estimate comes from a small sample of 50 patients in the high-copper group and carries substantial uncertainty. Their all-cause mortality risk was also dramatically higher, with an adjusted hazard ratio of 18.51.

On the other end of the spectrum, copper deficiency in the blood can also signal trouble in advanced liver disease. Among 183 patients with cirrhosis awaiting transplant evaluation, those who were copper-deficient (below 80 µg/dL for women or 70 µg/dL for men) had about 3.4 times the risk of dying before transplant compared to those with normal copper. This remained significant after adjusting for disease severity scores.

The most well-known copper-liver connection is Wilson disease, a genetic condition caused by mutations in the ATP7B gene. The liver loses its ability to export copper into bile, so copper accumulates in liver tissue and eventually overflows into the blood and brain. Wilson disease is rare (about 1 in 30,000 people), but if caught early it is highly treatable with copper-lowering medications.

Brain Health and Cognitive Decline

Copper plays a direct role in brain chemistry, helping produce the signaling molecules dopamine and norepinephrine. When copper regulation breaks down, the brain is vulnerable. A meta-analysis pooling data from roughly 6,000 participants across 56 studies found that copper levels are lower inside the brains of Alzheimer's disease patients but higher in their blood. The excess in blood comes from the "free" copper fraction not bound to ceruloplasmin.

In a longitudinal study following 141 people with mild cognitive impairment (MCI, an early warning stage), each additional unit of non-ceruloplasmin copper increased the chance of converting to full Alzheimer's dementia by about 20%. People with non-ceruloplasmin copper above 1.6 µmol/L converted to dementia at roughly three times the rate of those below that level over four years. This finding was independent of APOE4 genotype, the best-known genetic risk factor for Alzheimer's.

A separate meta-analysis focused specifically on depression found significantly higher serum copper in people with major depressive disorder compared to healthy controls across 24 studies, supporting a possible "trait marker" relationship between copper and mood.

Standard total serum copper, which is what most lab panels measure, captures both the ceruloplasmin-bound and free fractions combined. The research on Alzheimer's risk specifically implicates the free fraction. If you are tracking cognitive health, ask whether your lab can report non-ceruloplasmin copper or "free copper" alongside the total.

Cancer Risk

In the ORDET cohort from Italy, women in the highest third of the plasma copper-to-zinc ratio had about 75% higher odds of developing breast cancer compared to those in the lowest third, after adjusting for lifestyle and reproductive factors. When both plasma and urine copper-to-zinc ratios were simultaneously elevated, the odds rose to roughly 2.4 times higher. These associations were strongest for cancers diagnosed within two years of blood draw, suggesting copper may reflect biologically active tumor-promoting conditions.

Reference Ranges

Serum copper reference intervals differ by sex. Women naturally carry higher levels due to estrogen's effect on ceruloplasmin, the main copper-carrying protein. Pregnancy pushes levels even higher. The ranges below come from healthy adults measured using specialized lab techniques that detect copper with high precision. Your lab may report in different units or use a different analytical method, so always compare your results within the same lab over time.

No major guideline currently defines risk-stratified "optimal" or "longevity" cutpoints for serum copper. The ranges above are statistical boundaries from healthy populations, not disease-risk tiers. Compare your results within the same lab over time for the most meaningful trend.

When Results Can Be Misleading

Serum copper is heavily confounded by factors unrelated to your actual copper stores. Knowing what can push the number around will save you from overreacting to a single reading.

• Estrogen and oral contraceptives: Estrogen stimulates the liver to produce more ceruloplasmin, which carries copper. Women on combined oral contraceptives consistently show serum copper and ceruloplasmin levels 60 to 100% higher than non-users. This does not mean they have copper toxicity. It means their carrier protein is elevated, dragging total copper up with it. Pregnancy produces a similar or even larger effect.
• Inflammation and acute illness: Copper and ceruloplasmin both rise as part of the body's inflammatory response. Any infection, surgery, injury, or chronic inflammatory condition (rheumatoid arthritis, inflammatory bowel disease) can push copper up temporarily. If you have recently been sick, wait at least two to four weeks before drawing copper.
• Age, sex, and BMI: Women have about 14% higher copper than men. Copper tends to rise with age and with higher body mass, partly through low-grade inflammation. These shifts are normal and do not indicate disease, but they can move your result within or outside standard ranges.
• Nutritional proteins: Albumin and ceruloplasmin change with protein-energy nutrition and liver synthetic function. Malnutrition, liver cirrhosis, or severe illness can lower these proteins, altering the total copper reading independently of your actual copper balance.

Tracking Your Trend

A single copper reading is a snapshot taken through a noisy lens. Research on 68 healthy adults measured weekly for 10 weeks found that the within-person biological variation for serum copper is about 7.8%. That means your copper can swing by roughly 8% from week to week based on normal physiology alone, before any confounders like illness or hormonal shifts are factored in.

The same study found "marked individuality" for copper, meaning the range that is normal for you may be a narrow band within the broad population reference interval. Population-based cutpoints can miss a meaningful change in your personal trend. This is exactly why serial tracking matters: two or three readings over six to twelve months reveal your personal set point and whether your level is drifting.

Get a baseline, ideally when you are healthy, not fasting (copper is not significantly affected by meals, but consistency helps), and not on estrogen-containing medications. If you are making changes to diet or supplementation, retest in three to six months. After that, annual monitoring is reasonable. If your result is outside the reference range or if you are tracking a known condition, more frequent testing (every three to six months) is appropriate.

What to Do With an Abnormal Result

If your copper comes back high, the first step is to rule out the most common confounders: estrogen use, recent illness, or inflammation. Check hs-CRP at the same draw. If CRP is also elevated, the copper rise may simply reflect an inflammatory state rather than true copper overload. Retest when the acute process has resolved.

If copper is persistently elevated without an obvious confounder, the next layer of investigation depends on what you are tracking. For cardiovascular risk, pair copper with ApoB, a lipid panel, and hs-CRP. For liver health, add ALT (alanine aminotransferase), AST (aspartate aminotransferase), and GGT (gamma-glutamyl transferase). If Wilson disease is a concern (particularly in someone under 40 with unexplained liver or neurological symptoms), the workup should include ceruloplasmin, 24-hour urinary copper, and potentially exchangeable copper or genetic testing for ATP7B mutations. A hepatologist (liver specialist) or geneticist is the right specialist for that pathway.

If copper is low, particularly below 70 µg/dL in men or 80 µg/dL in women, consider whether malabsorption, poor dietary intake, or zinc supplementation could be the cause. Zinc competes with copper for absorption, and high-dose zinc taken chronically is a well-documented cause of copper deficiency. Low copper warrants a complete blood count to check for anemia or low white cell counts, which are early signs of functional copper depletion.